By Alex Lu
20 February 2020, 5:57 PM
Despite a reduction in earnings forecasts, our target price rises due to updates to peer multiples and a roll-forward of our model to FY21 forecasts.
Read more...
By Violeta Todorova
20 February 2020, 11:21 AM
Emeco Holdings (EHL), AMP Ltd (AMP), Beach Energy (BPT), Tabcorp Holdings (TAH) and Corporate Travel Management (CTD)
Read more...
By Andrew Tang
20 February 2020, 10:43 AM
Three stock's we're happy to buy today – Sonic Healthcare (SHL), Lovisa Holdings Ltd (LOV) and Accent Group Ltd (AX1)
Read more...
By Adrian Prendergast
19 February 2020, 1:15 PM
Despite reporting no direct impact on demand, sales, deliveries or payments stemming from the Coronavirus, BHP decided to remain conservative by not flexing its H1 dividend and keeping gearing at the low end of its target range.
Read more...
By Max Vickerson
19 February 2020, 11:00 AM
The ongoing impact from the coronavirus has given the market a buying opportunity for BPT.
Read more...
By Andrew Tang
18 February 2020, 10:57 AM
One stock we're happy to buy today – QBE Insurance Group (QBE)
Read more...
By Michael Knox
17 February 2020, 9:50 AM
Individual tax cuts and rising real wages means more Americans are seeking work.
Read more...
By Violeta Todorova
09 November 2020, 12:00 AM
Morgans Senior Technical Analyst Violeta Todorova provides detailed perspectives on The A2 Milk Company (A2M), Lovisa (LOV), Stavely Minerals (SVY), West African Resources (WAF) and Perseus Mining (PRU).
Read more...
By Andrew Tang
24 August 2020, 12:00 AM
We are happy to buy the following stocks: Coca-Cola Amatil, Santos, Beacon Lighting, Pro Medicus, InvoCare, Waypoint REIT, The Start Entertainment Group and Perpetual Limited
Read more...
By Raymond Chan
24 April 2020, 12:00 AM
新冠肺炎疫苗真可快將面世？
世界各地法寶盡出，奮力對抗新型冠狀病毒肺炎這個共同「敵人」，可惜迄今為止只能拖慢疫情擴散的速度，顯得治標不治本。其實，大家都明白到，若要成功戰勝新冠肺炎，唯一最有效的方法就是成功研發出疫苗。
很大程度上要感謝中國，在疫情初期就分享了新冠肺炎病毒的基因排序，目前已經有至少60種候選新冠肺炎疫苗，正在經由多間藥廠、生物科技公司和研究機構進行試驗
抗疫最強「武器」 臨床試驗階段
目前為止，美國生物科技公司 Moderna Therapeutics 所研發的疫苗 mRNA-1273，是最讓各方人士期盼的抗疫最強「武器」。此疫苗已經在美國華盛頓州進行臨床試驗，用於此次疫情中的高危群體，例如是前線醫護人員
澳洲的科研人員也不甘後人，現正加快進行大規模的人體測試，觀察過去幾十年以來一直用於治療肺結核病的現成疫苗，能否有效地保護前線醫護人員免受新冠肺炎感染。臨床測試中的新冠肺炎疫苗 Bacillus Calmette-Guerin（簡稱BCG），將會用於分布在澳洲全國各地的4,000位醫院前線醫護人員，務求從中了解此疫苗能否有效地紓緩新冠肺炎的病徵
BCG疫苗原本是用於對付...
Read more...